Skip to main content

Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology

  • Protocol
  • First Online:
Autoantibodies

Abstract

The innate immune complement system is a powerful defense cascade against pathogens, but can induce host tissue damage when overactivated. In pathological conditions, mainly but not restricted to renal diseases, such as lupus nephritis, atypical hemolytic uremic syndrome, and C3 glomerulopathies, complement is overactivated or dysregulated by autoantibodies directed against its components and regulators. Among the key autoantibody targets are the initiator of the classical complement pathway C1q, the alternative pathway regulator Factor H, the components of the alternative pathway C3 convertase complex C3 and Factor B and the convertase complex itself. This methodological article describes our experience with a method for detection of anti-complement autoantibodies in real time using surface plasmon resonance-based technology. It allows label-free evaluation of the binding efficacy and stability of the formed antigen–antibody complexes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part II: role in immunity. Front Immunol 6:257. https://doi.org/10.3389/fimmu.2015.00257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I - Molecular mechanisms of activation and regulation. Front Immunol 6:262. https://doi.org/10.3389/fimmu.2015.00262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Roumenina LT, Rayes J, Frimat M, Fremeaux-Bacchi V (2016) Endothelial cells: source, barrier, and target of defensive mediators. Immunol Rev 274:307–329. https://doi.org/10.1111/imr.12479

    Article  CAS  PubMed  Google Scholar 

  4. Degn SE, Jensenius JC, Thiel S (2011) Disease-causing mutations in genes of the complement system. Am J Human Genet 88:689–705. https://doi.org/10.1016/j.ajhg.2011.05.011

    Article  CAS  Google Scholar 

  5. Dragon-Durey MA, Blanc C, Marinozzi MC, van Schaarenburg RA, Trouw LA (2013) Autoantibodies against complement components and functional consequences. Mol Immunol 56:213–221. https://doi.org/10.1016/j.molimm.2013.05.009

    Article  CAS  PubMed  Google Scholar 

  6. Hristova MH, Stoyanova VS (2017) Autoantibodies against complement components in systemic lupus erythematosus–role in the pathogenesis and clinical manifestations. Lupus 26:1550–1555. https://doi.org/10.1177/0961203317709347

    Article  CAS  PubMed  Google Scholar 

  7. Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D (2012) Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP. Immunobiology 217:684–691. https://doi.org/10.1016/j.imbio.2011.11.007

    Article  CAS  PubMed  Google Scholar 

  8. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 21:3115–3121. https://doi.org/10.1093/ndt/gfl436

    Article  CAS  PubMed  Google Scholar 

  9. Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, van Kooten C, Daha MR (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679–688. https://doi.org/10.1172/JCI21075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Engel R, Rensink I, Roem D, Brouwer M, Kalei A, Perry D, Zeerleder S, Wouters D, Hamann D (2015) ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients. J Immunol Methods 426:114–119. https://doi.org/10.1016/j.jim.2015.08.011

    Article  CAS  PubMed  Google Scholar 

  11. Blanc C, Roumenina LT, Ashraf Y, Hyvärinen S, Sethi SK, Ranchin B, Niaudet P, Loirat C, Gulati A, Bagga A, Fridman WH, Sautès-Fridman C, Jokiranta TS, Frémeaux-Bacchi V, Dragon-Durey MA (2012) Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome. J Immunol 189:3528–3537. https://doi.org/10.4049/jimmunol.1200679

    Article  CAS  PubMed  Google Scholar 

  12. Durey MA, Sinha A, Togarsimalemath SK, Bagga A (2016) Anti-complement-factor H-associated glomerulopathies. Nat Rev Nephrol 12:563–578. https://doi.org/10.1038/nrneph.2016.99

    Article  CAS  PubMed  Google Scholar 

  13. Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V (2017) C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney Int 92:1232–1241. https://doi.org/10.1016/j.kint.2017.04.017

    Article  CAS  PubMed  Google Scholar 

  14. Paixao-Cavalcante D, López-Trascasa M, Skattum L, Giclas PC, Goodship TH, de Córdoba SR, Truedsson L, Morgan BP, Harris CL (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82:1084–1092. https://doi.org/10.1038/ki.2012.250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J, Frimat M, Ulinski T, Deschênes G, Burtey S, Delahousse M, Moulin B, Legendre C, Frémeaux-Bacchi V, Le Quintrec M (2017) Anti-Factor B and Anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN. J Am Soc Nephrol 28:1603–1613. https://doi.org/10.1681/ASN.2016030343

    Article  PubMed  PubMed Central  Google Scholar 

  16. Vasilev V, Noe R, Dragon-Durey MA, Chauvet S, Lazarov VJ, Deliyska BP, Fremeaux-Bacchi V, Dimitrov JD, Roumenina LT (2015) Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis. J Biol Chem 290:25343–25355. https://doi.org/10.1074/jbc.M115.647008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C (2017) Autoantibodies targeting ficolin-2 in systemic lupus erythematosus patients with active nephritis. Arthritis Care Res 70(8):1263–1268. https://doi.org/10.1002/acr.23449

    Article  CAS  Google Scholar 

  18. Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA (2015) Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. J Immunol 194:5129–5138. https://doi.org/10.4049/jimmunol.1402770

    Article  CAS  PubMed  Google Scholar 

  19. Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M (2012) Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis Rheum 64:3706–3714. https://doi.org/10.1002/art.34605

    Article  CAS  PubMed  Google Scholar 

  20. Dragon-Durey MA, Blanc C, Roumenina LT, Poulain N, Ngo S, Bordereau P, Fremeaux-Bacchi V (2014) Anti-factor H autoantibodies assay. Methods Mol Biol 1100:249–256. https://doi.org/10.1007/978-1-62703-724-2_20

    Article  CAS  PubMed  Google Scholar 

  21. Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M (2016) Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome. Mol Immunol 70:47–55. https://doi.org/10.1016/j.molimm.2015.12.005

    Article  CAS  PubMed  Google Scholar 

  22. Trojnar E, Józsi M, Uray K, Csuka D, Szilágyi Á, Milosevic D, Stojanović VD, Spasojević B, Rusai K, Müller T, Arbeiter K, Kelen K, Szabó AJ, Reusz GS, Hyvärinen S, Jokiranta TS, Prohászka Z (2017) Analysis of linear antibody epitopes on factor H and CFHR1 using sera of patients with autoimmune atypical hemolytic uremic syndrome. Front Immunol 8:302. https://doi.org/10.3389/fimmu.2017.00302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from Agence Nationale de la Recherche ANR JCJC - INFLACOMP 2015-2018 ANR-15-CE15-0001 to LTR, RILA grant to MADD (Campus France 36666QH) and MR (№DNTS/France 01/11), ANR COMPC3 ANR-16-CE18-0015 to VFB, EU FP7 grant 2012-305608 (EURenOmics) to VFB, APHP-PHRC AOM08198 to VFB, and by INSERM.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lubka T. Roumenina .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Noe, R. et al. (2019). Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology. In: Houen, G. (eds) Autoantibodies. Methods in Molecular Biology, vol 1901. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8949-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8949-2_24

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8948-5

  • Online ISBN: 978-1-4939-8949-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics